Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY New LLP Coverage Rule Aimed to Transform Industry Rather Than Eke Out Savings: LDP Social Security Chief
January 15, 2024
-
BUSINESS GSK’s Arexvy Hits Market as Japan’s 1st RSV Vaccine
January 15, 2024
-
BUSINESS Ono Poised to Overcome Opdivo Patent Cliff and Go Fully Global under New President
January 12, 2024
-
REGULATORY MHLW Study Underway on Lab Monkey Shortage, Research Team Frets Dependence on Specific Sources
January 11, 2024
-
BUSINESS New LLP Coverage Rule Loathed by Off-Patent Drug Makers but Innovative Players Hail Reform
January 10, 2024
-
REGULATORY Handling of Big-Seller Candidates Is Top Priority as Japan Seeks Good Budget Balance: Minister
January 10, 2024
-
ORGANIZATION FPMAJ Stands Firmly Against Full Implementation of Off-Year Price Revision in FY2025
January 9, 2024
-
BUSINESS Santen, Astellas, 3 More Firms Hit by Manufacturing Delays after Quake
January 9, 2024
-
BUSINESS Equa, Betanis and More Brands Gird for Generic Entry in 2024; Xarelto Contenders Too?
January 5, 2024
-
BUSINESS After New Year’s Quake, Wholesalers See Challenges in Drug Delivery to North Part of Noto Peninsula
January 5, 2024
-
REGULATORY FY2024 Reform Heralds Shift to Funding Cycle within Drug Budget: MHLW Pharma Director
December 28, 2023
-
TRENDS Top 10 Most-Read PHARMA JAPAN Articles in 2023
December 28, 2023
-
BUSINESS Amylyx Gears Up to Bring New ALS Drug to Japan Market: Country Chief
December 27, 2023
-
REGULATORY Japan Officially Drops Japanese PI Requirement before Global Trial Entry
December 26, 2023
-
REGULATORY (Update) Sawai Slapped with Biz Improvement Order over Rigged Quality Tests
December 25, 2023
-
BUSINESS Sawai Slapped with Biz Improvement Order over Rigged Quality Tests
December 22, 2023
-
ORGANIZATION Reform Package Is “First Step” towards Global Standard, but More Work Remains: JPMA
December 22, 2023
-
REGULATORY Japan to Roll Out New LLP Coverage Rule in October; 18 Billion Yen Saving Eyed for FY2024
December 21, 2023
-
REGULATORY Japan to Cut Drug Prices by 0.97% on Healthcare Cost Basis in FY2024
December 20, 2023
-
REGULATORY Gist of FY2024 Drug Pricing Reform
December 20, 2023
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…